Process for the synthesis of n-alkyl-4-pyridinamines
WO2020025579A1
Solid dosage form of quetiapine fumarate
WO2019102009A1
Process for the synthesis of a cyclodextrin derivative
WO2019096996A1
A process to obtain a tetrahydroisoquinoline derivative
WO2019025521A1
NEW POLYMORPHIC FORM OF A PYRAZINO[2,3-h][3]BENZAZEPINE DERIVATIVE
EP3178824A1
Process for preparing pimecrolimus
EP2924024A2
Solid forms of lorcaserin hydrochloride
WO2014060575A2
Process for the enantioselective synthesis of a tetrahydrobenzazepine compound
EP2835370A1
New crystals of dabigatran etexilate mesylate
EP2499914A1
Antiseptic solutions comprising di-(4-chlorophenyldiguanidino)-hexane and an anionic dye and their preparation
WO2012123325A1
NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
EP2468751A2
Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
EP2616466A2
Process for determining the suitability for distribution of a batch of a thiophene-2-carboxamide derivative
WO2011158194A1
Enzymatic resolution of racemic (2r,s)-2-(acetylamino)-3-methoxy-n-(phenylmethyl)propanamide
EP2581375A2
Improved methods for the preparation of quinoxaline derivatives
EP2522662A1
Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
EP2536394A2
Stabilized phenylcarbamate derivative in solid state
EP2501676A2
A di(4-chloro-phenyldiguanido) derivative which is free of potential genotoxicity and a process for reducing the residual amount of p-chloroaniline in said di(4-chloro-phenyldiguanido) derivative
WO2011039369A2
Amorphous forms of a 2-amino-4-(4-fluorobenzylamino)phenylcarbamate derivative
